The Street Still Highly Skeptical On AxoGen's Growth Story [Seeking Alpha]
Axogen, Inc. (AXGN)
Last axogen, inc. earnings: 2/24 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.axogeninc.com
Company Research
Source: Seeking Alpha
The Street Still Highly Skeptical On AxoGen's Growth Story Summary Amidst worries about market size, competition, trial design, and executive turnover, AxoGen has also suffered from a rotation away from growth med-tech that had propelled sector multiples to long-term highs. The expansion of the RECON study will push potential FDA approval of an Avance BLA back by around two years, but the RMAT designation suggests some degree of FDA confidence. With 30% annualized revenue growth potential over the next five years and better than 20% long-term growth potential, the shares look undervalued below $30. It’s rough for investors when institutions change their mind about growth sectors, and the performance of some smaller high-growth med-techs over the past year illustrates that, with Abiomed ABMD AXGN Avanos AVNS Inogen INGN Nevro NVRO Of course, it’s not just sector allocation that matters, and AxoGen has had some of its own challenges, including a late 2018 short report that rattled inves
Show less
Read more
Impact Snapshot
Event Time:
AXGN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AXGN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AXGN alerts
High impacting Axogen, Inc. news events
Weekly update
A roundup of the hottest topics
AXGN
News
- Axogen, Inc. to Report First Quarter 2024 Financial Results and Host Conference Call on May 2, 2024GlobeNewswire
- Analysts Expect Breakeven For AxoGen, Inc. (NASDAQ:AXGN) Before Long [Yahoo! Finance]Yahoo! Finance
- Director Gregory Freitag Sells 25,000 Shares of Axogen Inc (AXGN) [Yahoo! Finance]Yahoo! Finance
- US$13.80 - That's What Analysts Think AxoGen, Inc. (NASDAQ:AXGN) Is Worth After These Results [Yahoo! Finance]Yahoo! Finance
- AxoGen, Inc. (NASDAQ:AXGN) Q4 2023 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
AXGN
Earnings
- 3/5/24 - Beat
AXGN
Sec Filings
- 4/24/24 - Form DEF
- 4/24/24 - Form ARS
- 4/4/24 - Form PRE
- AXGN's page on the SEC website